Previous 10 | Next 10 |
home / stock / ipatf / ipatf news
ImmunoPrecise Increases Private Placement Financing Canada NewsWire VICTORIA, May 30, 2018 VICTORIA , May 30, 2018 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. ("ImmunoPrecise" or "IPA") (TSX VENTURE: IPA)(OTC PINK: IPATF) announces that it has increased its previously an...
ImmunoPrecise Announces Private Placement Financing Canada NewsWire VICTORIA, May 29, 2018 VICTORIA , May 29, 2018 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. ("ImmunoPrecise" or "IPA") (TSX VENTURE: IPA)(OTC PINK: IPATF) announces that it proposes to complete a non-brokered ...
ImmunoPrecise Appoints Jennifer Bath to Board of Directors and Expands Senior Leadership to Further Global Growth Canada NewsWire VICTORIA, BC, May 24, 2018 VICTORIA, BC , May 24, 2018 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. ("ImmunoPrecise" or "IPA") (TSX VENTURE: IPA)(O...
ImmunoPrecise Opens U.S. Headquarters in Fargo, North Dakota Canada NewsWire VICTORIA, May 18, 2018 VICTORIA , May 18, 2018 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA)(OTC PINK: IPATF) announces the opening of its U.S. Headquarters ...
ImmunoPrecise Opens New Full Service B-Cell Facility Canada NewsWire VICTORIA, April 27, 2018 VICTORIA , April 27, 2018 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. ("ImmunoPrecise" or "IPA") (TSX VENTURE: IPA)(OTC PINK: IPATF) announces the opening of its new, innovative...
ImmunoPrecise Announces Oversubscription to Debenture Financing Canada NewsWire VICTORIA, April 6, 2018 VICTORIA , April 6, 2018 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. ("ImmunoPrecise") (TSX VENTURE: IPA)(OTC PINK: IPATF) announces it has completed a final tranche t...
ImmunoPrecise Acquires ModiQuest Research BV Canada NewsWire VICTORIA, BC, April 6, 2018 Immediately Accretive by Adding EBITA of Approximately C$750,000 with Increased Synergies, Scale and Efficiency Strategic Acquisition Allows ImmunoPrecise to Provide Comprehensive...
Immunoprecise Antibodies Delivers Record Quarterly Revenue of $1.723 Million and Increases Gross Margins To 54% Canada NewsWire VICTORIA, March 28, 2018 VICTORIA , March 28, 2018 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX Venture: IPA, OTC ...
ImmunoPrecise enters into definitive agreement to acquire ModiQuest Research BV Canada NewsWire VICTORIA, March 16, 2018 VICTORIA , March 16, 2018 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "Immunoprecise") (TSX VENTURE: IPA)(OTC PINK: IPATF) is pleased to ...
LOS ANGELES, CA / ACCESSWIRE / March 8, 2017 / ImmunoPrecise (OTC PINK: IPATF), a full-service, custom, therapeutic antibody discovery CRO, announced that it will be presenting at the inaugural LD Micro Virtual Conference on Thursday, March 8th at 3 PM PST / 6 PM EST. CEO and President, Jenn...
News, Short Squeeze, Breakout and More Instantly...
ImmunoPrecise Antibodies Ltd. Company Name:
IPATF Stock Symbol:
OTCMKTS Market:
ImmunoPrecise Antibodies to Begin Trading on Nasdaq Stock Exchange Canada NewsWire VICTORIA, BC , Dec. 23, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSXV: IPA) (Nasdaq Global Markets: IPA), a leader in full-service, therapeu...
ImmunoPrecise Reports Financial Results and Recent Business Highlights for Second Quarter of 2021 Fiscal Year Canada NewsWire Record Quarterly Revenue of $4,754,545 and Adjusted EBITDA of $795,159 Announced Strategic Partnership ...
ImmunoPrecise and LiteVax Advance SARS-CoV-2 Vaccine Candidate VICTORIA, BC , Dec. 14, 2020 /PRNewswire/ - IMMUNOPRECISE ANTIBODIES LTD. ("IPA") (TSXV: IPA) (IPATD: IPA) (FSE: TQB), a leader in full-service, therapeutic antibody discovery and development and LiteVax...